Women’s imaging encompasses many radiology procedures related to women and the diseases that are most prevalent to women such as breast cancer or gynecological issues. Mammogram, breast ultrasound, breast MRI and breast biopsy are the most commonly used procedures.
Two respected radiology organizations have issued a stark warning on the new recommendations, stating that they risk confusing patients and “may contribute to thousands of additional breast cancer deaths each year.”
New Hampshire is one of the latest after Republican Gov. Chris Sununu signed House Bill 1296 into law May 31, eliminating OOP expenses for supplemental services.
This reduction protocol allows for acceptable lesion visualization while also providing a cautionary cushion when the safety of sequential contrast injections is in question.
Although DBT exams are proven to identify more difficult to detect cancers, especially among women with dense breasts, they also include significantly more images than standard 2D mammograms.
The Class I recall, which is the most serious recall the FDA issues, comes after numerous adverse events and complications linked to the radiographic markers were reported.
UPDATED: The alert pertains to the BioZorb and BioZorb LP radiographic markers, implanted in soft tissue to indicate the site for radiation therapy or other medical procedures.